This two-day meeting consists of expert plenary lectures, oral abstract presentations, and poster-viewing sessions. In order to maintain an interactive environment, much time will be allocated to Q&A and discussions.
Efficient drug development of novel anticancer treatments
Drug combinations and Drug interactions
Pharmacometrics in drug development and clinical practice
Biomarker for dose selection in the 2020's
We will share the complete program soon and please find below some of our confirmed speakers: